Seminars in Spine Surgery
Volume 20, Issue 4 , Pages 240-247 , December 2008

The Multiply Operated Spine: Chronic Pain Medical Management

  • Neil Jobalia, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Neil Jobalia, MD, c/o Elisha Clouse, Orthopaedic Diagnostic and Treatment Center, 4600 Smith Road, Suite B, Cincinnati, OH 45212

References 

  1. Brander VA, Stulberg SD, Adams AD, et al. Predicting total knee replacement pain: a prospective, observational study. Clin Orthop Relat Res. 2003;416:27–36
  2. Remy C, Marret E, Bonnet F. Effects of acetaminophen on morphine side effects and consumption after major surgery: meta-analysis of randomized controlled trials. Br J Anaesth. 2005;94:505–513
  3. Kehlet H, Dahl JB. The value of “multimodal” or “balanced analgesia” in postoperative pain treatment. Anesth Analg. 1993;77:1048–1056
  4. Reuben SS, Gutta SB, Maciolek H, et al. Effect of initiating a multimodal analgesic regimen upon patient outcomes after anterior cruciate ligament reconstruction for same-day surgery: a 1200-patient case series. Acute Pain. 2004;6:87–93
  5. Unnerstall JR, Kopajtic TA, Kuhar MJ. Distribtuion of alpha 2 agonist binding sites in the rat and human central nervous system: analysis of some functional, anatomic correlates of the pharmacologic effects of clonidine and related adrenergic agents. Brain Res. 1984;319:69–101
  6. Physicians Desk Reference 2007
  7. Adriaensen H, Vissers K, Noorduin H, et al. Opioid tolerance and dependence: an inevitable consequence of chronic treatment?. Acta Anaesthesiol Belg. 2003;54(1):37–47
  8. Rhodin L, Grönbladh L, Nilsson T, et al. Methadone treatment of chronic non-malignant pain and opioid dependence—a long-term follow-up. Eur J Pain. 2006;10(3):271–278
  9. Elander J, Lusher J, Bevan D, et al. Understanding the causes of problematic pain management in sickle cell disease: evidence that pseudoaddiction plays a more important role than genuine analgesic dependence. J Pain Symptom Manage. 2004;27(2):156–169
  10. Lusher J, Elander J, Bevan D. Analgesic addiction and pseudoaddiction in painful chronic illness. Clin J Pain. 2006;22(3):316–324
  11. Chu LF, Clark DJ, Angst MS. Opioid tolerance and hyperalgesia in chronic pain patients after one month of oral morphine therapy: a preliminary prospective study. J Pain. 2006;7(1):43–48
  12. Katz N, Fanciullo GJ. Role of urine toxicology testing in the management of chronic opioid therapy. Clin J Pain. 2002;18(suppl 4):S76–S82
  13. Challapalli V, Tremont-Lukats IW, McNicol ED. Systemic administration of local anesthetic agents to relieve neuropathic pain. Cochrane Database Syst Rev. 2005;19(4):CD00334587
  14. Sindrup SH, Otto M, Finnerup NB, et al. Antidepressants in the treatment of neuropathic pain. Basic Clin Pharm Toxicol. 2005;96(6):399–409
  15. Atkinson JH, Slater MA, Capparelli EV, et al. Efficacy of noradrenergic and serotonergic antidepressants in chronic back pain: a preliminary concentration-controlled trial. J Clin Psychopharmacol. 2007;27(2):135–142
  16. Gilron I, Peter C, Watson N. Neuropathic pain: a practical guide for the clinician. CMAJ. 2006;175:265–275
  17. Gilron I, Bailey JM, Tu D. Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med. 2005;352:1324
  18. Battistella M, Mamdami M, Juurlink D. Risk of upper gastrointestinal hemorrhage in warfarin users treated with nonselective NSAIDs or COX-2 inhibitors. Arch Int Med. 2005;165:189–192
  19. White WB, West CR, Borer JS, et al. Risk of cardiovascular events in patients receiving celecoxib: a meta-analysis of randomized clinical trials. Am J Cardiology. 2007;99:91–98
  20. Bhattacharyya T, Smith RM. Cardiovascular risks of coxibs: the orthopaedic perspective. J Bone Joint Surg Am. 2005;87:245–246
  21. Bombardier C, Laine L, Reicin A, et al. VIGOR Study Group Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. N Engl J Med. 2000;343:1520–1528
  22. Browning R, Jackson JL, O'Malley PG. Cyclobenzaprine and back pain: a meta-analysis. Arch Int Med. 2001;161(13):1613–1620
  23. Gammaitoni AR, Alvarez NA, Galer BS. Safety and tolerability of the lidocaine patch 5%, a targeted peripheral analgesic: a review of the literature. J Clin Pharmacol. 2003;43(2):111–117
  24. Gaumann DM, Brunet PC, Jirounek P. Clonidine enhances the effects of Lidocaine on C-fiber action potential. Anesth Analg. 1992;74:719–725
  25. Gaumann D, Forster A, Griessen M, et al. Comparison between clonidine and epinephrine admixture to Lidocaine in brachial plexus block. Anesth Analg. 1992;75:69–74
  26. Porter SE, Hanley EN. The musculoskeletal effects of smoking. J Am Acad Orthop Surg. 2001;9(1):9–17
  27. Flor H, Fydrich T, Turk DC. Efficacy of multidisciplinary pain treatment centers: a meta-analytic review. Pain. 1992;49(2):221–230
  28. Miller B, Gatchel RJ, Lou L, et al. Interdisciplinary treatment of failed back surgery syndrome (FBSS): a comparison of FBSS and non-FBSS patients. Pain Practice. 2005;5(3):190–202
  29. van Tulder MW, Koes B, Malmivaara A. Outcome of non-invasive treatment modalities on back pain: an evidence-based review. Eur Spine J. 2005;15(suppl 1):S64–S81
  30. Reuben SS, Buvanendran A. Preventing the development of chronic pain after orthopaedic surgery with preventive multimodal analgesic techniques. J Bone Joint Surg Am. 2007;89:1343–1358

PII: S1040-7383(08)00077-4

doi: 10.1053/j.semss.2008.10.001

Seminars in Spine Surgery
Volume 20, Issue 4 , Pages 240-247 , December 2008

Article Tools

* Image Usage & Resolution